Methotrexate Injection, Solution
Product Images NDC 61703-161

7 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 61703-161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methotrexate 01)

Chemical Structure (Methotrexate 01)
Chemical structure diagram of Methotrexate, showing its molecular framework including multiple nitrogen atoms, amino groups, and carboxylic acid groups.*
FDA Label Image

Logo (Methotrexate 01a)

FDA Label Image

Logo (Methotrexate 01b)

FDA Label Image

Principal Display Panel (40 mL Vial Label)

Principal Display Panel (40 mL Vial Label)
Label for Methotrexate Injection, USP 1 g/40 mL (25 mg/mL) solution for injection in a 40 mL single-dose vial. It is indicated for intravenous, intramuscular, subcutaneous, and intrathecal use. The label notes it is a hazardous drug, preservative free, and manufactured by Hospira, Inc. The label includes a barcode and NDC 61703-124-40.*
FDA Label Image

Principal Display Panel (40 mL Vial Carton)

Principal Display Panel (40 mL Vial Carton)
Packaging label for Methotrexate Injection, USP, 25 mg/mL (1 g/40 mL) preservative-free solution for injection by Hospira, Inc. The label indicates use for intramuscular, intrathecal, intravenous, and subcutaneous routes. It includes dosage form details, manufacturer information, hazardous drug warnings, and storage instructions, with the bar code and lot number area clearly visible.*
FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
Label for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) isotonic liquid in a sterile 2 mL multiple-dose vial. The label indicates the product contains a preservative and is for intravenous, intramuscular, and subcutaneous use only. Distributed by Hospira, Inc., Lake Forest, IL, USA. The label includes NDC 61703-161-02 and a warning to see prescribing information.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
Packaging label for Methotrexate Injection, USP sterile isotonic liquid by Hospira, Inc. The label indicates a strength of 50 mg/2 mL (25 mg/mL) in multiple 2 mL vials. It notes usage for intravenous, intramuscular, and subcutaneous administration and includes warnings that the drug contains preservative and is not for intrathecal use. The label is marked with a red band stating "Hazardous Drug."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.